Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

BIOLASE Inc (NASDAQ:BIOL)

1.00
Delayed Data
As of 12:13pm ET
 +0.03 / +3.09%
Today’s Change
0.80
Today|||52-Week Range
1.98
-28.57%
Year-to-Date
No recent news for BIOLASE Inc.

Today’s Trading

Previous close0.97
Today’s open1.01
Day’s range0.97 - 1.01
Volume11,393
Average volume (3 months)62,168
Market cap$65.9M
Dividend yield--
Data as of 12:13pm ET, 06/29/2017

Growth & Valuation

Earnings growth (last year)+17.14%
Earnings growth (this year)+44.83%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+7.68%
P/E ratioNM
Price/Sales1.64
Price/Book2.97

Competitors

 Today’s
change
Today’s
% change
MLSSMilestone Scientific...+0.04+2.80%
PDEXPro-Dex Inc-0.20-3.28%
ALGNAlign Technology Inc-2.54-1.67%
XRAYDentsply Sirona Inc-0.75-1.15%
Data as of 12:27pm ET, 06/29/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$51.8M
Annual profit (last year)-$15.4M
Net profit margin-29.67%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Harold C. Flynn
Vice President-
Operations
Richard R. Whipp
Corporate headquarters
Irvine, California

Forecasts